Human Requirements for the Nutrient Choline

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

43 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-06-30

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to increase our understanding of how much choline humans need to get from their diet. Choline is an essential nutrient found in many foods, including eggs and milk. In addition to dietary sources, choline can be made in the liver. Choline is important in making membranes or wrappers for all the cells in the body and for making chemicals that allow nerve cells to work properly. In a previous study we found that the dietary requirement for choline varies greatly from person to person. This was caused, in part, by how much estrogen a person has and their genetic makeup. We are conducting this study to explore how estrogen levels and specific differences in genes influence choline requirements so that we can refine the dietary recommendations for this nutrient.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Whole Egg Intake and Choline Concentration in the Aging Brain

NCT05021211

Alzheimer Disease

COMPLETED

Dietary Supplementation to Increase Serum Choline Levels

NCT02403804

Healthy

COMPLETED NA

The Effect of Daily Consumption of Eggs on Cognitive Function in the Elderly

NCT01621646

Mild Cognitive Impairment

COMPLETED NA

Choline Supplementation and Cardiovascular Health

NCT03646175

Cardiovascular Risk Factor

COMPLETED NA

The Conversion of ENcapsulated GlucorAphanin, Gut Microbiota Phylogeny and gEnotype Study (ENGAGE)

NCT01927666

Healthy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Choline is an essential nutrient essential used for the structural integrity and signaling functions of cell membranes, cholinergic neurotransmission, and lipid transport/metabolism. Choline is obtained from the diet and from endogenous biosynthesis catalyzed by the enzyme phosphatidylethanolamine N-methyltransferase (PEMT). The major premise for this proposal is that humans require a dietary source of choline and that this requirement has significant individual variation and is modulated by estrogen and common genetic polymorphisms. The promoter of the PEMT gene is estrogen responsive, and we hypothesize that estrogen status influences the dietary requirement for choline. We identified other common single nucleotide polymorphisms (SNPs) that increase or decrease the likelihood that a human will develop organ dysfunction when fed a low choline diet. Experiments are proposed that will refine our understanding of estrogen-mediated induction of the PEMT promoter; determine whether postmenopausal women treated with estrogen have a decreased susceptibility to developing organ dysfunction associated with choline deficiency; determine the prevalence of SNPs that increase susceptibility to choline deficiency in the population and examine dietary choline requirements in humans with these SNPs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postmenopausal Women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Post-menopausal women randomized to receive estrogen replacement therapy.

Group Type ACTIVE_COMPARATOR

Estrogen plus choline depletion diet

Intervention Type OTHER

Post-menopausal subjects receive estrogen and are then challenged with a low choline diet to determine if estrogen protects them from induction of choline deficiency.

2

Post-menopausal women randomized to receive a placebo.

Group Type PLACEBO_COMPARATOR

Placebo plus choline depletion diet

Intervention Type OTHER

Post-menopausal women are randomized to receive a placebo and are then subjected to a low choline diet to determine if clinical signs of choline deficiency can be induced.

3

Pre-menopausal women with specific genetic variants.

Group Type EXPERIMENTAL

Pre-menopausal women with SNPs given a low choline diet

Intervention Type OTHER

Pre-menopausal women with specific genetic polymorphisms in genes related to choline metabolism are placed on a choline depletion diet to determine if the SNPs increase or decrease the risk of diet-induced choline deficiency.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Estrogen plus choline depletion diet

Post-menopausal subjects receive estrogen and are then challenged with a low choline diet to determine if estrogen protects them from induction of choline deficiency.

Intervention Type OTHER

Placebo plus choline depletion diet

Post-menopausal women are randomized to receive a placebo and are then subjected to a low choline diet to determine if clinical signs of choline deficiency can be induced.

Intervention Type OTHER

Pre-menopausal women with SNPs given a low choline diet

Pre-menopausal women with specific genetic polymorphisms in genes related to choline metabolism are placed on a choline depletion diet to determine if the SNPs increase or decrease the risk of diet-induced choline deficiency.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy
* Non-smoker
* BMI between 18 and 34
* Normal mammogram in last 12 months (post-menopausal women only)

Exclusion Criteria

* Hormone or estrogen therapy
* Allergic to soy, eggs, wheat
* History of breast, uterine, or other estrogen-dependent cancer
* Liver or kidney problems
* History of circulation, bleeding, or blood-clotting disorder
* Anemia or evidence of iron overload
* Hyperthyroidism, neurological disorder, or autoimmune disease
* Diabetes controlled by insulin
* Positive serology for HIV or Hepatitis B or C
* Alcohol or illegal drug misuse/abuse
* Pacemaker, aneurysm clip, cardiac heart valve, mechanical devices/implants
* Other metal in body (i.e. injured by a BB, shrapnel, or metallic object)

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes